Medical device firm St. Jude Medical has introduced new SyncAV cardiac resynchronization therapy (CRT) software across the globe, including Japan.
SyncAV CRT software algorithm has been designed to function independently to address and effectively treat heart failure patients who will not respond to other pacing options.
For heart failure patients, CRT technology resynchronizes the lower chambers of the heart by sending uniquely programmed electrical impulses to stimulate each ventricle to beat in sync to offer better cardiac performance.
SyncAV technology holds capacity to automatically adjust pacing based on real-time changes in a patient’s cardiac condition.
It also enables physicians to improve treatment for patients who have responded positively to traditional CRT.
The technology is compatible with existing Quadra Assura CRT-D and Allure Quadra CRT-P which are already MRI conditional.
Japan-based Saitama Medical Center Jichi Medical University’s Dr Takeshi Mitsuhashi said: “We have made great improvements in how we are managing heart failure patients, but certain patients still do not get the desired outcomes from traditional CRT.
St. Jude Medical chief medical officer and global clinical affairs vice president Dr Mark Carlson said: “St. Jude Medical remains dedicated to continued leadership in heart failure management, helping physicians to manage some of their most complex patients.”
“SyncAV CRT technology is another important advance that can help physicians manage their patients.”
Image: St. Jude Medical has launched new SyncAV cardiac resynchronization therapy (CRT) software. Photo: courtesy of Stuart Miles / FreeDigitalPhotos.net.